Alan is an internationally recognised Health Economist, expert advisor to the NHS, the pharmaceutical industry and a number of regulatory and funding authorities. Previously he was employed as Regional Health Economist in the North West Regional Health Authority, assisting in the prioritisation of healthcare provision to the population of the North West. He is a member of the National Institute for Health and Care Excellence (NICE) Technology Appraisals Committee and he is a founder of the Liverpool Technology Assessment Review (TAR) and Liverpool Health Economics (LHE). He specialises in pharmacoeconomic evaluation and has worked with an extensive range of pharmaceutical companies, guiding the economic evaluation of the new pharmaceutical products. His work is widely published and he is also a reviewer for a range of high profile journals.